Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Adjuvant Targeted Therapy NSCLC, Japanese Trials

Masahiro Tsuboi

MD, PhD

🏢National Cancer Center Hospital East, Japan🌐Japan

Chief of Thoracic Surgery

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Masahiro Tsuboi led Japanese adjuvant EGFR TKI trials including IMPACT and contributed to ADAURA as co-investigator, shaping global perioperative standards in EGFR-mutant NSCLC. His surgical-oncologic work integrates molecular selection with resection planning. He pioneered neoadjuvant targeted and perioperative ctDNA monitoring approaches in Asia.

Share:

🧪Research Fields 研究领域

IMPACT trial
Japanese adjuvant EGFR TKI trials
resectable NSCLC surgery
neoadjuvant targeted therapy
perioperative strategies

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Masahiro Tsuboi 的研究动态

Follow Masahiro Tsuboi's research updates

留下邮箱,当我们发布与 Masahiro Tsuboi(National Cancer Center Hospital East, Japan)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment